文献速递主动脉外科

当代急性A型主动脉夹层非手术治疗:结局更优?

Contemporary nonsurgical management of acute type A aortic dissection: Better outcomes?
PubMed 文献 · J Thorac Cardiovasc Surg · 2022-09-22

该研究评估1996年至2021年单中心999例急性A型主动脉夹层患者中非手术治疗的结局。非手术队列148例因严重合并症、灌注不良综合征所致器官衰竭或患者意愿未手术,其院内加30天死亡率为70%,手术队列为7.9%。第二十年(2011-2021)非手术患者死亡率较第一十年(1996-2010)降低,3年生存率提高。

要点

  • 非手术队列院内加30天死亡率为70%,手术队列为7.9%。
  • 非手术队列第二十年(2011-2021)死亡率58%,低于第一十年(1996-2010)的87%。
  • 非手术队列中,壁内血肿患者院内加30天死亡率52%,低于经典A型夹层的72%。

核心结论

  • 手术仍是急性A型主动脉夹层的主流治疗。
  • 非手术治疗对因合并症或灌注不良综合征而不适合手术者仍有作用,尤其是急性A型壁内血肿患者。

研究设计与样本

  • 单中心回顾性研究,纳入1996年1月至2021年12月共999例急性A型主动脉夹层患者,其中839例接受开放主动脉修复(手术队列),148例因严重合并症、灌注不良综合征所致器官衰竭或患者意愿接受非手术治疗(非手术队列)。
  • 数据来源于病历回顾、胸外科医师学会仓库、国家死亡指数和密歇根死亡指数数据库。

主要发现

  • 非手术队列院内加30天死亡率为70%,手术队列为7.9%,非手术队列是手术队列的9倍。
  • 非手术队列中,第二十年(2011-2021)患者院内加30天死亡率为58%,低于第一十年(1996-2010)的87%(P<.001)。
  • 非手术队列中,第二十年主动脉破裂发生率为8%,低于第一十年的21%(P=.008);3年生存率为29%,高于第一十年的13%(P=.005)。
  • 非手术队列中,灌注不良综合征患者与无灌注不良综合征患者院内加30天死亡率相似,但主动脉破裂发生率更高(21% vs 6.1%,P=.01),比值比为4.2(P=.03)。
  • 非手术队列中,壁内血肿患者院内加30天死亡率为52%,低于经典A型夹层的72%(P=.02),比值比为0.36(P=.02)。

临床怎么用

  • 手术仍是急性A型主动脉夹层的主流治疗;非手术治疗对因合并症或灌注不良综合征而不适合手术者仍有作用,尤其是急性A型壁内血肿患者(作者结论)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to evaluate outcomes of nonsurgically managed acute type A aortic dissection (ATAAD) in the contemporary era. METHODS: From January 1996 to December 2021, 999 patients presented with ATAAD at our institution, of whom 839 patients underwent open aortic repair (surgical cohort) whereas 148 patients were managed nonoperatively (nonsurgical cohort) because of severe comorbidities, organ failure from malperfusion syndrome, and patients' wishes. Data were obtained from chart review, the Society of Thoracic Surgeons warehouse, the national death index, and Michigan death index database. RESULTS: The combined in-hospital + 30-day mortality rate was 9 times higher in the nonsurgical cohort compared with the surgical cohort (70% vs 7.9%). In the nonsurgical cohort, compared with the first decade (1996-2010), patients during the second decade (2011-2021) had a lower in-hospital+30-day mortality rate (58% vs 87%; P<.001); lower incidence of aortic rupture (8% vs 21%; P=.008), and a higher 3-year survival rate (29% vs 13%; P=.005). Within the nonsurgical cohort, compared with patients without malperfusion syndrome, the patients with malperfusion syndrome had similar in-hospital + 30-day mortality but a greater incidence of aortic rupture (21% vs 6.1%, P=.01) with an odds ratio of 4.2 (P=.03); compared with classic type A dissection, the patients with intramural hematoma had a lower in-hospital+30-day mortality rate (52% vs 72%, P=.02) with an odds ratio of 0.36 (P=.02). CONCLUSIONS: Surgery remained the mainstream treatment for ATAAD. Nonsurgical management still had a role for those who were not surgical candidates because of comorbidities or malperfusion syndrome, especially in those with acute type A intramural hematoma.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Ahmad RA, Orelaru F, Titsworth M, et al. Contemporary nonsurgical management of acute type A aortic dissection: Better outcomes? J Thorac Cardiovasc Surg. 2022. PMID: 36272767. doi:10.1016/j.jtcvs.2022.09.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。